Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma

Despite a better understanding in head and neck tumors pathogenesis as well as improvements in radiotherapy and surgery, locally advanced head and neck squamous cell carcinoma (HNSCC) remains of poor prognosis. One promising target is the epidermal growth factor receptor (EGFR), which is overexpress...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Eleonore Longton, Kathleen Schmit, Maude Fransolet, François Clement, Carine Michiels
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018-10-01
Colecção:Frontiers in Oncology
Assuntos:
head and neck squamous cell carcinoma
afatinib
combined therapy
treatment schedule
cisplatin
Acesso em linha:https://www.frontiersin.org/article/10.3389/fonc.2018.00432/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados